Levosimendan: Calcium Sensitizer and Inodilator
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,General Medicine
Reference19 articles.
1. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients in beta-blockers;Bergh;Eur J Heart Fail,2010
2. Drug treatment of patients with decompensated heart failure;Mills;Am J Cardiovasc Drugs,2001
3. Steering committee and investigators of the levosimendan infusion versus dobutamine (LIDO) study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a random double-blind trial;Follath;Lancet,2002
4. Zairis MN, Apostolatos C, Anastasiadis P, et al. The effect of a calcium sensitizer or an inotrope or none in chronic low output decompensated heart failure: results from the Calcium Sensitizer or Inotrope or None in Low Output Heart Failure Study (CASINO) [abstract 835–6]. Program and abstracts from the American College of Cardiology Annual Scientific Sessions 2004. New Orleans, LA, March 7–10, 2004.
5. Clinical trials update from the American heart association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE;Cleland;Eur J Heart Fail,2006
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Use of Levosimendan in Patients with Advanced Heart Failure: An Update;Journal of Clinical Medicine;2022-10-29
2. Intranasal levosimendan prevents cognitive dysfunction and apoptotic response induced by repeated isoflurane exposure in newborn rats;Naunyn-Schmiedeberg's Archives of Pharmacology;2021-03-27
3. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery;Annals of Cardiac Anaesthesia;2021
4. Cardiovascular Agents;Pediatric Critical Care;2021
5. Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-Analysis;Frontiers in Pediatrics;2020-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3